Forte Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Forte Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,575	Closed	-$203K	–	58
2023 Q1	$203K	Buy	+1,575	New	+$206K	0.13%	60
2022 Q4	–	Sell	-2,429	Closed	-$284K	–	67
2022 Q3	$284K	Sell	2,429 -665	-21%	-$82.6K	0.19%	58
2022 Q2	$364K	Buy	+3,094	New	+$367K	0.25%	55

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Forte Asset Management's IBB Position: Q2 2023 in Review

Forte Asset Management sold out of iShares Biotechnology ETF (IBB) in Q2 2023, closing a stake of 1,575 shares — an estimated $203K sold.

Forte Asset Management first reported a position in IBB in Q2 2022 and held it in 3 quarters. The position peaked at $364K in Q2 2022. 843 funds tracked by Wall St. Rank hold IBB as of Q2 2023.

Forte Asset Management reported no remaining iShares Biotechnology ETF position as of Q2 2023 after selling out during the quarter.
Forte Asset Management sold 1,575 iShares Biotechnology ETF shares in Q2 2023, an estimated $203K.
Forte Asset Management first reported a position in iShares Biotechnology ETF in Q2 2022 and held it in 3 quarters.
Forte Asset Management's iShares Biotechnology ETF position peaked at $364K in Q2 2022.
843 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2023.

Based on Forte Asset Management's 13F filing for Q2 2023, filed 17 Jul 2023.